Senior Consultant, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System
Administrative Appointment(s)
Director, National University Cancer Institute, Singapore, National University Health System
Head, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, National University Health System
Deputy Director, Cancer Science Institute of Singapore, National University of Singapore
Vice-Dean, Research, NUS Yong Loo Lin School of Medicine
Group Director, Research Office, National University Health System
Leader, Haematologic Malignancy Tumour Group, National University Cancer Institute, Singapore, National University Health System
Lead, Cancer Summit Research Programme, National University Health System
1. de Mel, S., Soon, G. S. -T., Mok, Y., Chung, T. -H., Jeyasekharan, A. D., Chng, W. -J., & Ng, S. -B. (2018). The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.. Int J Mol Sci, 19(7). doi:10.3390/ijms19071931.
2. Soekojo, C. Y., de Mel, S., Ooi, M., Yan, B., & Chng, W. J. (2018). Potential clinical application of genomics in multiple myeloma. International Journal of Molecular Sciences, 19(6). doi:10.3390/ijms19061721.
3. Shanmugam, M. K., Ahn, K. S., Lee, J. H., Kannaiyan, R., Mustafa, N., Manu, K. A., . . . Kumar, A. P. (2018). Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma. FRONTIERS IN PHARMACOLOGY, 9, 11 pages. doi:10.3389/fphar.2018.00365.
4. Zhou, J., Chooi, J. -Y., Ching, Y. Q., Quah, J. Y., Toh, S. H. -M., Ng, Y., . . . Chng, W. -J. (2018). NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28B. WORLD JOURNAL OF STEM CELLS, 10(4), 34-42. doi:10.4252/wjsc.v10.i4.34.
5. Zhou, J., Toh, S. H. -M., Chan, Z. -L., Quah, J. Y., Chooi, J. -Y., Tan, T. Z., . . . Chng, W. -J. (2018). A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/beta-catenin pathways for treatment of AML with high PRL-3 phosphatase. JOURNAL OF HEMATOLOGY & ONCOLOGY, 11, 12 pages. doi:10.1186/s13045-018-0581-9.